| Sample | Title | Value | Rank |
|---|
| GSM549121 | patient 080, normal, homogenized [OPG study] | 3.87834 | 12 |
| GSM549102 | patient 115, normal, homogenized [OPG study] | 3.80897 | 11 |
| GSM549104 | patient 119, normal, homogenized [OPG study] | 4.52383 | 30 |
| GSM549108 | patient 138, normal, homogenized [OPG study] | 3.68189 | 7 |
| GSM549119 | patient 077, normal, homogenized [OPG study] | 3.84722 | 12 |
| GSM549133 | patient 032, cancer, homogenized [OPG study] | 3.80205 | 12 |
| GSM549139 | patient 042, cancer, homogenized [OPG study] | 3.65912 | 7 |
| GSM549099 | patient 107, normal, homogenized [OPG study] | 3.75676 | 9 |
| GSM549109 | patient 139, normal, homogenized [OPG study] | 3.86899 | 12 |
| GSM549110 | patient 046, normal, homogenized [OPG study] | 3.83271 | 11 |
| GSM549114 | patient 063, normal, homogenized [OPG study] | 3.73397 | 9 |
| GSM549122 | patient 082, normal, homogenized [OPG study] | 3.82939 | 11 |
| GSM549134 | patient 033, cancer, homogenized [OPG study] | 4.64874 | 33 |
| GSM549136 | patient 036, cancer, homogenized [OPG study] | 3.57565 | 6 |
| GSM549140 | patient 044, cancer, homogenized [OPG study] | 3.99913 | 17 |
| GSM549111 | patient 047, normal, homogenized [OPG study] | 3.8348 | 12 |
| GSM549113 | patient 057, normal, homogenized [OPG study] | 3.73655 | 10 |
| GSM549132 | patient 031, cancer, homogenized [OPG study] | 3.62056 | 6 |
| GSM549137 | patient 038, cancer, homogenized [OPG study] | 3.65766 | 7 |
| GSM549142 | patient 047, cancer, homogenized [OPG study] | 4.09503 | 16 |
| GSM549100 | patient 110, normal, homogenized [OPG study] | 3.69681 | 8 |
| GSM549107 | patient 135, normal, homogenized [OPG study] | 3.92973 | 15 |
| GSM549115 | patient 068, normal, homogenized [OPG study] | 3.60854 | 6 |
| GSM549116 | patient 072, normal, homogenized [OPG study] | 3.56134 | 4 |
| GSM549120 | patient 078, normal, homogenized [OPG study] | 3.59513 | 5 |
| GSM549131 | patient 030, cancer, homogenized [OPG study] | 3.93546 | 15 |
| GSM549118 | patient 074, normal, homogenized [OPG study] | 3.73383 | 9 |
| GSM549129 | patient 027, cancer, homogenized [OPG study] | 5.08279 | 42 |
| GSM549123 | patient 088, normal, homogenized [OPG study] | 3.66294 | 6 |
| GSM549124 | patient 006, cancer, homogenized [OPG study] | 3.52545 | 3 |
| GSM549126 | patient 015, cancer, homogenized [OPG study] | 4.24948 | 23 |
| GSM549128 | patient 025, cancer, homogenized [OPG study] | 4.15163 | 21 |
| GSM549103 | patient 117, normal, homogenized [OPG study] | 3.76026 | 9 |
| GSM549117 | patient 073, normal, homogenized [OPG study] | 3.92741 | 14 |
| GSM549138 | patient 041, cancer, homogenized [OPG study] | 3.74152 | 9 |
| GSM549141 | patient 045, cancer, homogenized [OPG study] | 4.07488 | 20 |
| GSM549130 | patient 028, cancer, homogenized [OPG study] | 3.63083 | 6 |
| GSM549101 | patient 111, normal, homogenized [OPG study] | 3.89012 | 13 |
| GSM549105 | patient 128, normal, homogenized [OPG study] | 3.70179 | 8 |
| GSM549106 | patient 134, normal, homogenized [OPG study] | 4.81213 | 37 |
| GSM549112 | patient 048, normal, homogenized [OPG study] | 3.83271 | 12 |
| GSM549125 | patient 011, cancer, homogenized [OPG study] | 3.70343 | 8 |
| GSM549127 | patient 024, cancer, homogenized [OPG study] | 4.31913 | 25 |
| GSM549135 | patient 035, cancer, homogenized [OPG study] | 3.66367 | 8 |